ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
3,427
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: results from a phase II Trial
Author(s):
LA Byers
,
LM Krug
,
SN Waqar
,
A Dowlati
,
CL Hann
,
A Chiappori
,
TK Owonikoko
,
KM Woo
,
Y Bensman
,
B Hurtado
Publication date:
Journal:
J Thorac Oncol
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Scientific Ocean Drilling Expedition Research Results
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
3,427
Efficacy of the combination of ABT-888 (veliparib) and carboplatin in patients with BRCA-associated breast cancer
Authors:
G Somlo
,
PH Frankel
,
TH Luu
…
DNA repair deficiency biomarkers and MammaPrint high1/(ultra)high2 risk as predictors of veliparib/carboplatin response: results from the neoadjuvant I‑SPY 2 trial for high risk breast cancer
Authors:
DM Wolf
,
C Yau
,
A Sanil
Abstract P3-07-48: prediction of complete pathologic response to veliparib/carboplatin plus standard neoadjuvant therapy in HER2 negative breast cancer: exploratory protein pathway marker results from the I-SPY 2 trial
Authors:
JD Wulfkuhle
,
C Yau
,
DM Wolf
See all similar
Cited by
1
Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
Authors:
Zoltan Lohinai
,
Zsolt Megyesfalvi
,
Balazs Döme
…
See all cited by